Lv11
30 积分 2023-05-17 加入
Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
6小时前
待确认
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
6小时前
已完结
A novel cuproptosis-related gene signature of prognosis and immune microenvironment in head and neck squamous cell carcinoma cancer
1个月前
已完结
Identification of genomic alterations in oesophageal squamous cell cancer
1个月前
已完结
The genetic spectrum of familial hypercholesterolemia in the central south region of China
3个月前
已完结
Saturation genome editing-based clinical classification of BRCA2 variants
4个月前
已完结
Functional evaluation and clinical classification of BRCA2 variants
4个月前
已完结
Biological and therapeutic implications of the cancer-related germline mutation landscape in lung cancer
4个月前
已完结
Clinical implications of CSF-ctDNA positivity in newly diagnosed diffuse large B cell lymphoma
5个月前
已完结
Philadelphia-chromosome positive acute lymphoblastic leukemia: ten frequently asked questions
6个月前
已完结
皖公网安备34019202002308
